Compare fund portfolios
See how two funds' portfolios overlap. Enter two tickers:
BBC vs PTH
Shared holdings
27
BBC covered by PTH
16.95%
PTH covered by BBC
16.95%
Coverage = share of one portfolio's weight reproduced by the other (overlapping positions, min weight). Top 50 positions per side shown; = held by both — hover a shared position to highlight it in both columns.
BBC (April 30, 2026)
| Security | Weight | |
|---|---|---|
| DREYFUS GOVT CASH MGMT FUND | 2.23% | |
| ERASCA INC | 2.14% | |
| ENLIVEN THERAPEUTICS INC | 1.77% | |
| TANGO THERAPEUTICS INC | 1.67% | |
| ORUKA THERAPEUTICS INC | 1.64% | |
| SPYRE THERAPEUTICS INC | 1.60% | |
| ALUMIS INC | 1.55% | |
| DIANTHUS THERAPEUTICS INC | 1.51% | |
| KODIAK SCIENCES INC | 1.32% | |
| REVOLUTION MEDICINES INC | 1.32% | |
| CORVUS PHARMACEUTICALS INC | 1.31% | |
| REZOLUTE INC | 1.29% | |
| DEFINIUM THERAPEUTICS INC | 1.26% | |
| CG ONCOLOGY INC | 1.18% | |
| JADE BIOSCIENCES INC | 1.18% | |
| INHIBRX BIOSCIENCES INC | 1.17% | |
| RELAY THERAPEUTICS INC | 1.17% | |
| GH RESEARCH PLC | 1.14% | |
| NEKTAR THERAPEUTICS | 1.12% | |
| TYRA BIOSCIENCES INC | 1.11% | |
| VIR BIOTECHNOLOGY INC | 1.10% | |
| INTELLIA THERAPEUTICS INC | 1.08% | |
| CENTESSA PHARMACEUTICALS LTD ADR | 1.08% | |
| ANAPTYSBIO INC | 1.06% | |
| OMEROS CORP | 1.04% | |
| TECTONIC THERAPEUTIC INC | 1.02% | |
| ALLOGENE THERAPEUTICS INC | 1.02% | |
| COMPASS Pathways PLC, ADR | 0.97% | |
| EDGEWISE THERAPEUTICS INC | 0.95% | |
| PALVELLA THERAPEUTICS INC | 0.94% | |
| CAPRICOR THERAPEUTICS INC | 0.93% | |
| VAXCYTE INC | 0.93% | |
| PHARVARIS NV | 0.93% | |
| ARRIVENT BIOPHARMA INC | 0.92% | |
| XENON PHARMACEUTICALS INC | 0.92% | |
| NEUROGENE INC | 0.90% | |
| SUMMIT THERAPEUTICS INC | 0.88% | |
| AMYLYX PHARMACEUTICALS INC | 0.88% | |
| CELLDEX THERAPEUTICS INC | 0.86% | |
| PRAXIS PRECISION MEDICINES INC | 0.86% | |
| ARCUS BIOSCIENCES INC | 0.86% | |
| ANNEXON INC | 0.85% | |
| TERNS PHARMACEUTICALS INC | 0.85% | |
| LIQUIDIA TECHNOLOGIES INC | 0.85% | |
| MONTE ROSA THERAPEUTICS INC | 0.85% | |
| IMMUNOME INC | 0.85% | |
| BICARA THERAPEUTICS INC | 0.84% | |
| CELCUITY INC | 0.83% | |
| IRONWOOD PHARMA CL A (PEND) | 0.83% | |
| AbCellera Biologics Inc COM | 0.83% |
PTH (Jan. 31, 2026)
| Security | Weight | |
|---|---|---|
| Invesco Private Prime Fund | 16.67% | |
| Invesco Private Government Fund | 7.65% | |
| PRAXIS PRECISION MEDICINES INC | 4.01% | |
| GUARDANT HEALTH INC | 3.37% | |
| ROIVANT SCIENCES | 3.21% | |
| TERNS PHARMACEUTICALS INC | 3.16% | |
| ARROWHEAD PHARMACEUTICALS INC | 3.16% | |
| NATERA INC | 2.68% | |
| REVOLUTION MEDICINES INC | 2.50% | |
| TENET HEALTHCARE CORP | 2.24% | |
| AXSOME THERAPEUTICS INC | 2.19% | |
| HCA HEALTHCARE INC | 2.15% | |
| CELCUITY INC | 2.14% | |
| MEDPACE HOLDINGS INC | 2.12% | |
| UNITED THERAPEUTICS CORP DEL | 1.93% | |
| BRIDGEBIO PHARMA INC | 1.90% | |
| MADRIGAL PHARMACEUTICALS INC | 1.77% | |
| COGENT BIOSCIENCES INC | 1.72% | |
| TRAVERE THERAPEUTICS INC | 1.55% | |
| PROTAGONIST THERAPEUTICS INC | 1.44% | |
| ENSIGN GROUP INC | 1.42% | |
| BRIGHTSPRING HEALTH SERVICES INC | 1.42% | |
| STOKE THERAPEUTICS INC | 1.39% | |
| ALIGNMENT HEALTHCARE INC | 1.33% | |
| HARROW INC | 1.25% | |
| PACS GROUP INC | 1.21% | |
| IMMUNOME INC | 1.16% | |
| MIRUM PHARMACEUTICALS INC | 1.13% | |
| TAYSHA GENE THERAPIES INC | 1.03% | |
| ARCUTIS BIOTHERAPEUTICS INC | 1.01% | |
| PTC THERAPEUTICS INC | 1.00% | |
| RAPT THERAPEUTICS INC | 1.00% | |
| LIGAND PHARMACEUTICALS | 0.90% | |
| NUVATION BIO INC | 0.88% | |
| IDEAYA BIOSCIENCES | 0.87% | |
| ALPHATEC HOLDINGS INC | 0.86% | |
| TARSUS PHARMACEUTICALS INC | 0.86% | |
| KYMERA THERAPEUTICS INC | 0.84% | |
| AMNEAL PHARM INC | 0.81% | |
| AXOGEN INC | 0.79% | |
| PRECIGEN INC | 0.71% | |
| KODIAK SCIENCES INC | 0.70% | |
| MONTE ROSA THERAPEUTICS INC | 0.66% | |
| PALVELLA THERAPEUTICS INC | 0.63% | |
| SIONNA THERAPEUTICS INC | 0.63% | |
| MAZE THERAPEUTICS INC | 0.63% | |
| REPLIMUNE GROUP INC | 0.62% | |
| TREVI THERAPEUTICS INC | 0.62% | |
| UPSTREAM BIO INC | 0.60% | |
| ORUKA THERAPEUTICS INC | 0.60% |
Machine-readable: JSON · Markdown. Programmatic access via the agent surface.